[HTML][HTML] Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP)

AE Fiore, A Fry, D Shay, L Gubareva, JS Bresee… - MMWR Recomm …, 2011 - cdc.gov
This report updates previous recommendations by CDC's Advisory Committee on
Immunization Practices (ACIP) regarding the use of antiviral agents for the prevention and …

[HTML][HTML] The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination

H Kelly, HA Peck, KL Laurie, P Wu, H Nishiura… - PloS one, 2011 - journals.plos.org
Background During the influenza pandemic of 2009 estimates of symptomatic and
asymptomatic infection were needed to guide vaccination policies and inform other control …

[HTML][HTML] Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study

S Riley, KO Kwok, KM Wu, DY Ning, BJ Cowling… - PLoS …, 2011 - journals.plos.org
Background While patterns of incidence of clinical influenza have been well described,
much uncertainty remains over patterns of incidence of infection. The 2009 pandemic …

[PDF][PDF] Influenza 2010-2011: lessons from the 2009 pandemic

MG Ison, N Lee - Cleve Clin J Med, 2010 - copanusa.com
Influenza 2010-2011: Lessons from the 2009 pandemic Page 1 EDUCATIONAL OBJECTIVE:
Readers will vaccinate their patients against influenza, suspect influenza in patients with …

[HTML][HTML] Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India

BV Tandale, SD Pawar, YK Gurav, MS Chadha… - BMC infectious …, 2010 - Springer
Abstract Background In India, Pune was one of the badly affected cities during the influenza
A (H1N1) 2009 pandemic. We undertook serosurveys among the risk groups and general …

[HTML][HTML] Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections

S Aranda-Romo, CA Garcia-Sepulveda… - Immunogenetics, 2012 - Springer
Introduction of a novel influenza virus into the human population leads to the occurrence of
pandemic events, such as the one caused by pandemic influenza A (H1N1) 2009 virus. The …

[HTML][HTML] Duration of viral shedding in hospitalized patients infected with pandemic H1N1

S Meschi, M Selleri, E Lalle, L Bordi, MB Valli… - BMC infectious …, 2011 - Springer
Background The first influenza pandemic of the 21th century was ignited by a new strain of
influenza A virus (A/H1N1pdm). Specific patient groups, including those with comorbidities …

Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting

KL Laurie, P Huston, S Riley, JM Katz, DJ Willison… - 2013 - Wiley Online Library
Please cite this paper as: Laurie et al.(2013) Influenza serological studies to inform public
health action: best practices to optimise timing, quality and reporting. Influenza and Other …

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact

DY Oh, S Lowther, JM McCaw… - Journal of …, 2014 - academic.oup.com
Objectives The emergence of the pandemic influenza A (H1N1) pdm09 virus in 2009 saw a
significant increase in the therapeutic and prophylactic use of neuraminidase inhibitors …

[PDF][PDF] Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy

RL Puleston, G Bugg, K Hoschler, J Konje… - Health Technol …, 2010 - academia.edu
UNCORRECTED PROOFS Page 1 DOI: 10.3310/hta14550-01 Health Technology Assessment
2010; Vol. 14: No. 55, 1–82 © 2010 Queen’s Printer and Controller of HMSO. All rights reserved …